| Pack Size/Qty | Price | Unit Price | |
| 6 Inhaler/s | $81.50 | $13.65 | |
| 3 Inhaler/s | $42.00 | $14.08 | |
| 1 Inhaler | $18.00 | $18.00 |
Generic Name : Budesonide
Brand Name : N/A
Manufacturer Name : Cipla Ltd - Pharmaceutical Company
Product Code : CRX 180
Delivery Days : 10 to 15 working days
Strength : 200 mcg
Packaging : Inhaler
Prescribed For : Fever, Sneezing, Cough, Abdominal Pain
Budecort Inhaler 200 mcg is a medication that belongs to the class of corticosteroids, specifically glucocorticoids. It is widely used in the management of various respiratory conditions, particularly asthma. This inhaler is valued for its effectiveness in reducing inflammation and preventing the symptoms associated with chronic respiratory disorders. In this detailed overview, we will explore the key aspects of Budecort Inhaler 200 mcg, including its composition, mechanism of action, indications, dosage, potential side effects, and precautions.
Budecort Inhaler 200 mcg contains the active ingredient budesonide, which is a synthetic corticosteroid. Each actuation delivers 200 micrograms of budesonide into the respiratory system. Budesonide is known for its potent anti-inflammatory properties, making it a crucial component in the treatment of respiratory conditions.
Budesonide exerts its therapeutic effects by acting on the inflammatory pathways involved in respiratory conditions. It binds to glucocorticoid receptors in the cells, leading to the activation of anti-inflammatory genes and the suppression of pro-inflammatory genes. This mechanism helps reduce inflammation in the airways, preventing the release of substances that contribute to bronchoconstriction and airway obstruction.
Budecort Inhaler 200 mcg is primarily indicated for the prophylactic treatment of asthma, including both allergic and non-allergic variants. It is particularly beneficial in cases where symptoms are not adequately controlled by bronchodilators alone. The inhaler is also used in the management of chronic obstructive pulmonary disease (COPD), helping to alleviate symptoms and improve lung function.
The recommended dosage of Budecort Inhaler 200 mcg varies depending on the severity of the condition and the individual patient's response. It is crucial to follow the prescribing physician's instructions carefully. Typically, the inhaler is administered as one or two inhalations twice daily. The patient should rinse their mouth with water after each use to minimize the risk of oral thrush, a potential side effect associated with inhaled corticosteroids.
It is essential for patients to be educated on the proper inhalation technique to ensure optimal drug delivery to the lungs. Proper use of the inhaler involves shaking it well before each use, exhaling fully before inhaling the medication, and holding the breath for a few seconds to allow for adequate drug deposition in the airways.
While Budecort Inhaler 200 mcg is generally well-tolerated, like any medication, it may be associated with certain side effects. Common side effects may include throat irritation, coughing, and oral thrush. To minimize the risk of oral thrush, patients are advised to rinse their mouths after using the inhaler. Systemic effects, such as adrenal suppression, are rare at the recommended doses for inhalation.
It is crucial for patients to promptly report any unusual or severe side effects to their healthcare provider. Additionally, regular follow-up appointments are recommended to monitor the patient's response to treatment and adjust the dosage if necessary.
Budecort Inhaler 200 mcg is contraindicated in patients with a known hypersensitivity to budesonide or any other components of the inhaler. It should be used with caution in patients with active or latent tuberculosis, fungal, bacterial, or viral infections, as corticosteroids may suppress the immune response.
Special attention is required for patients with a history of systemic corticosteroid use, as abrupt discontinuation of systemic steroids may lead to adrenal insufficiency. When transitioning from systemic corticosteroids to inhaled budesonide, a gradual tapering of the systemic steroid dose may be necessary.
Pregnant and breastfeeding women should use Budecort Inhaler 200 mcg only if the potential benefits justify the potential risks to the fetus or infant. It is essential for healthcare providers to weigh the risks and benefits in such cases and closely monitor the patient's condition.
Budecort Inhaler 200 mcg is a valuable tool in the management of asthma and chronic obstructive pulmonary disease. Its active ingredient, budesonide, effectively reduces inflammation in the airways, leading to improved respiratory symptoms and lung function. By following the prescribed dosage and instructions, patients can experience the benefits of this corticosteroid while minimizing the risk of side effects. As with any medication, open communication with healthcare providers is crucial to ensuring the best possible outcomes for individuals using Budecort Inhaler 200 mcg in their respiratory care regimen.
